StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Constant Currency Growth in Rest of World (% cc) by Quarter

Constant Currency Growth in Rest of World (% cc) (%)

QuarterlyAnnual

Novartis Constant Currency Growth in Rest of World (% cc): -3.0% in Q3 2026, down 10.0 pts from a year earlier.

Latest, Q3 2026
-3.0%
Period ended Sep 30, 2026
Change on a year earlier
-10.0 pts
7.0% in Q3 2025
History
32 quarters
Since Q4 2018
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Sandostatin Group | Established brands | Carcinoid tumors, acromegaly | 187 | 6 | 124 | – 2 | – 3 | 311 | 3 | 3”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConstant Currency Growth in Rest of World (% cc) (%)Year on yearSource
Q3 2026Sep 30, 2026-3.0%-10.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20267.0%+15.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-2.0%-11.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20252.0%-1.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20257.0%+5.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 2025-8.0%-11.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 20259.0%+9.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 20243.0%-15.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 20242.0%-14.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 20243.0%-15.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 20240.0%-6.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202318.0%+34.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 202316.0%+30.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202318.0%+38.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 20236.0%+20.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-16.0%-8.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Constant Currency Growth in Rest of World (% cc) (%), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-sandostatin-group-row-yoy-cc-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.